scholarly journals The efficacy of oral melatonin in improving sleep in cancer patients with insomnia: A randomized double-blind placebo-controlled study

2016 ◽  
Vol 22 (3) ◽  
pp. 295 ◽  
Author(s):  
MadhuriS Kurdi ◽  
SindhuPriya Muthukalai
Keyword(s):  
Cancer Patients ◽  
Controlled Study ◽  
Double Blind ◽  
Double Blind Placebo

scholarly journals Clinical Evaluation of Ramosetron Injections in the Treatment of Cisplatin-Induced Nausea and Vomiting

2002 ◽  
Vol 30 (3) ◽  
pp. 211-219 ◽  
Author(s):  
K Noda ◽  
M Ikeda ◽  
O Yoshida ◽  
S Yano ◽  
T Taguchi ◽  
...  
Keyword(s):  
Cancer Patients ◽  
Clinical Efficacy ◽  
Clinical Evaluation ◽  
Adverse Reactions ◽  
Phase Iii ◽  
Controlled Study ◽  
Double Blind ◽  
Safety And Efficacy ◽  
Double Blind Placebo ◽  
Efficacy Analysis

A phase III, double-blind, placebo-controlled study was performed to examine the safety and efficacy of ramosetron in cancer patients with cisplatin-induced nausea/vomiting. Patients were divided into two groups: group R received 0.3 mg ramosetron intravenously and group P received placebo. Eighty-eight patients were enrolled, 44 in each group; 84 (43 in group R, 41 in group P) were included in the clinical efficacy analysis and 86 (44 in group R, 42 in group P) in the safety analysis. Ramosetron was significantly more clinically effective than placebo against nausea, vomiting and anorexia; 65.1% of patients in group R experienced no vomiting in the first 6 h of observation compared with 7.3% of those receiving placebo. No serious adverse reactions or significant differences in safety were observed between the groups. Based on these results, ramosetron injection is effective in the treatment of cisplatin-induced nausea/vomiting and its clinical usefulness is demonstrated here.

Impact of the preoperative use of synbiotics in colorectal cancer patients: A prospective, randomized, double-blind, placebo-controlled study

Nutrition ◽  
2019 ◽  
Vol 58 ◽  
pp. 40-46 ◽  
Author(s):  
Camila Brandão Polakowski ◽  
Massakazu Kato ◽  
Vinicius Basso Preti ◽  
Maria Eliana Madalozzo Schieferdecker ◽  
Antonio Carlos Ligocki Campos
Keyword(s):  
Colorectal Cancer ◽  
Cancer Patients ◽  
Controlled Study ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Colorectal Cancer Patients

scholarly journals Randomized, double-blind, placebo-controlled study of methylphenidate for the treatment of depression in SSRI-treated cancer patients receiving palliative care

2016 ◽  
Vol 26 (11) ◽  
pp. 1763-1769 ◽  
Author(s):  
Donald R. Sullivan ◽  
Solange Mongoue-Tchokote ◽  
Motomi Mori ◽  
Elizabeth Goy ◽  
Linda Ganzini
Keyword(s):  
Palliative Care ◽  
Cancer Patients ◽  
Controlled Study ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Treatment Of Depression
Sign in / Sign up

Export Citation Format

Share Document